Vadim Shepel

Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.

Cennerv Pharmaceuticals Ltd. engages in the pharmaceutical development specializing in CNS disorders with an initial focus on mental health such as depression, insomnia, dementia, schizophrenia and autism. The company was founded on July 13, 2015 and is headquartered in Singapore.

NYU Innovation Venture Fund, seeks investment opportunities in companies located in the United States. The fund targets start-up companies operating in the fields of information technology, computer software and biotechnology, especially by current NYU students, faculty, and researchers. It provides equity financing for seed capital requirements with an investment size ranging from USD 100,000 to 1 million. The fund does not invest in projects requiring further basic research.

NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY.

Amyriad Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. Amyriad Therapeutics, Inc. focuses on developing therapies for the relief of Alzheimer's disease symptoms. The company was founded by Christian Angermayer, Thomas Hanke, Anil K. Ratty, Marlon Braumann. The CEO is Sharon L. Rogers.

Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.

Part of Kiora Pharmaceuticals, Inc., Jade Therapeutics, Inc. develops pharmaceutical products. The company is based in Salt Lake City, UT. The company was founded by Barbara Wirostko. Jade Therapeutics was acquired by Kiora Pharmaceuticals, Inc. on March 07, 2016 for $5.10 million.

Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL.

Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA.